Better outcomes through patient education and integrated care

Nowadays, guidelines propagate a personalized, multimodal treatment concept. In addition to prescribing drug therapy that is tailored to the severity of COPD, there are numerous other factors that can be used to counteract acute exacerbations and the associated morbidity and mortality risks. This is the subject of numerous studies in which barriers to optimal disease management are identified and strategies are presented to improve the status quo.